Over-the-counter drug · ANDA
Maximum Strength Acid Reducer (famotidine) NDC 11673-697
Famotidine 20 mg/1 · Tablet · Oral · TARGET CORPORATION
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 11673-697-01 | 11673069701 | 2 BOTTLE in 1 CARTON (11673-697-01) / 50 TABLET in 1 BOTTLEMarketed from May 15, 2024 | |
| 11673-697-05 | 11673069705 | 1 BOTTLE in 1 CARTON (11673-697-05) / 50 TABLET in 1 BOTTLEMarketed from May 15, 2024 | |
| 11673-697-20 | 11673069720 | 1 BOTTLE in 1 CARTON (11673-697-20) / 200 TABLET in 1 BOTTLEMarketed from May 15, 2024 | |
| 11673-697-52 | 11673069752 | 5 BLISTER PACK in 1 CARTON (11673-697-52) / 5 TABLET in 1 BLISTER PACKMarketed from May 15, 2024 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Maximum Strength Acid Reducer
- Generic name (nonproprietary)
- famotidine
- Active ingredients
- Famotidine — 20 mg/1
- Dosage form
- Tablet
- Route
- Oral
- Labeler
- TARGET CORPORATION
- Product type
- Over-the-counter drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 217543
- Marketing start
- Listing expires
- Other FDA classes
- Histamine H2 Receptor Antagonists (Mechanism)
- Identifiers
- Product ID 11673-697_18567eaf-6b97-8c6f-e063-6294a90a986dSPL ID 18567eaf-6b97-8c6f-e063-6294a90a986dSPL set ID 07a924f1-14cc-4e7d-e063-6394a90ac7f3RxCUI 310273UNII 5QZO15J2Z8
- Pharmacologic class
- Histamine-2 Receptor Antagonist
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N411673069701followed by a unit qualifier and the quantityPackage 11673-0697-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Uses relieves heartburn associated with acid indigestion and sour stomach prevents heartburn associated with acid indigestion and sour stomach brought on by eating or drinking certain food and beverages
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 217543
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Original strength heartburn preventionfamotidine | Famotidine 10 mg/1 | TabletOral | KROGER COMPANY | 41226-719 |
| Maximum Strength Acid Reducerfamotidine | Famotidine 20 mg/1 | TabletOral | TIME CAP LABORATORIES,INC | 49483-720 |
| Maximum Strength Acid Controllerfamotidine | Famotidine 20 mg/1 | TabletOral | BETTER LIVING BRANDS LLC. | 21130-027 |
| Famotidine 10 mg | Famotidine 10 mg/1 | Tablet, CoatedOral | MARKSANS PHARMA LIMITED | 25000-086 |
| Famotidine 20 mg | Famotidine 20 mg/1 | Tablet, CoatedOral | MARKSANS PHARMA LIMITED | 25000-087 |
| Famotidine 20 mg | Famotidine 20 mg/1 | Tablet, CoatedOral | MARKSANS PHARMA LIMITED | 25000-124 |